Welcome!
Stock Exchange of Hong Kong (HKEx)
IPO
Singapore biotech firm Mirxes refiles HK IPO with target valuation of US$600 million
If successful, Mirxes will be the largest biotech listing from Singapore on the HKEx.
May 07, 2024
IPO
Singapore-headquartered Mirxes secures US$50 mil in Series D funding; files listing application with HKEx
The funding came from new and existing investors including EDB Investments Pte Ltd.
July 26, 2023
Markets
Phillip Capital Management launches and lists Phillip HK Newly Listed Equities Index ETF in Hong Kong
Co-designed and developed between Solactive and PCMHK, the ETF tracks the Solactive Hong Kong Newly Listed Equities Index.
November 21, 2022
IPO
Singapore’s 2017 IPO activity to surpass that of 2016: PwC
SINGAPORE (July 3): The volume of IPO funds raised by end-2017 is expected to surpass 2016 levels with professional services leading the way as the sector with the most funds raised, according to PricewaterhouseCoopers (PwC) Singapore.
July 03, 2017